Group 1 - Shanghai Port Bay (605598.SH) reported its Q3 2025 results, with 10 institutional investors holding a total of 187 million shares, representing 76.27% of the total share capital [1] - The top ten institutional investors include Shanghai Longwan Investment Holding Co., Ltd., Ningbo Longwan Venture Capital Partnership, and several funds from China Merchants Bank and Industrial and Commercial Bank of China [1] - Compared to the previous quarter, the combined holding percentage of the top ten institutional investors decreased by 0.35 percentage points [1] Group 2 - In the public fund sector, six new public funds were disclosed this period, including several funds from the Oriental Red series [2] - A total of 46 public funds were not disclosed compared to the previous quarter, including funds from GF Securities and E Fund [2] - The foreign investment perspective saw the absence of Hong Kong Central Clearing Limited in the current disclosures [2]

Group 1 - Xianle Health (300791.SZ) reported its Q3 2025 results, with 11 institutional investors holding a total of 160 million shares, representing 52.02% of the total share capital [1] - The top ten institutional investors include notable firms such as Guangdong Guanghui Investment Co., Ltd. and Xuan Yuan Private Equity Fund Management (Guangdong) Co., Ltd., with their combined holding ratio increasing by 0.45 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, five funds increased their holdings, accounting for a 1.76% increase, including funds like Dongfanghong JD Big Data Mixed A and Guangda Baodexin Credit Added Bond A [2] - One new public fund, Tianhong Huili Mixed A, was disclosed this period, while 107 public funds were not disclosed compared to the previous quarter, including funds like China Merchants Industry Selected Stock A and Nord Value Advantage Mixed [2]

Group 1 - Zhenghai Biological (300653.SZ) released its Q3 2025 report on October 25, 2025, indicating that as of October 24, 2025, six institutional investors disclosed holdings in Zhenghai Biological A-shares, totaling 21.9322 million shares, which accounts for 12.18% of the total share capital [1] - The institutional investors include Longwood Biotechnologies Inc., Jiaxing Zhenghai Venture Capital Partnership (Limited Partnership), Industrial and Commercial Bank of China - Dongfanghong New Power Flexible Allocation Mixed Securities Investment Fund, and others, with a total institutional holding ratio increasing by 0.33 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, four public funds increased their holdings compared to the previous period, including Dongfanghong New Power Mixed A, Medical Device ETF, and others, with an increase in holding ratio of 0.94% [2] - A total of 43 public funds did not disclose their holdings in this period compared to the previous quarter, including Taiping Fenghe One-Year Open-Ended Bond Initiated Fund, Dongfanghong Zhihua Three-Year Holding Mixed A, and others [2]